- PMID: 39503169
- DOI: 10.1002/cam4.70395
Abstract
Background: High dose chemotherapy is one of the therapeutic strategies for breast cancer and doxorubicin (DOX) as a chemotherapy agent is widely used. DOX indication is limited due to its dose-depended cardiotoxicity. Recently, cannabidiol (CBD) shows antitumoral and cardioprotective effects, so we hypothesized that CBD administration with high-dose DOX chemotherapy can improve anticancer activity and reduce cardiotoxic side effects.
Method: Mice breast cancer model established by injecting 4T1 cell lines. One group was not injected by 4T1 cells as a not cancerous group and received normal saline (NS, 0.1 mL). In cancerous groups, first group was considered as cancerous control and received NS (0.1 mL); the second group received CBD (5 mg/kg, IP) on Days 1,7, and 14; in the third group DOX (5 mg/kg, IV) as CBD schedule was administrated; the fourth group treated with CBD 1 day before DOX injection as pretreatment, and the last group was treated with CBD and DOX at same time with previous doses and schedules. On Day 21, all mice were sacrificed, heart and lungs tissues were obtained and histological sections were isolated. SOD2, iNOS, MMP2, MMP9 were evaluated through western blot and TUNEL test preformed for breast tumor.
Results: Tumor size and weight significantly decreased in DOX, pretreatment CBD + DOX and CBD + DOX groups. Administration of CBD with DOX could not prevent weight loss. TUNEL test demonstrated the highest tumor cell apoptosis in pretreatment CBD + DOX and CBD + DOX. In lungs belonged to CBD + DOX, there was not any sign of metastasis. Cardiac histopathological examination of pretreatment CBD + DOX and CBD + DOX did not show any sign of congestion or inflammation. In CBD + DOX SOD2 increased, also iNOS, MMP2, and MMP9 decreased compared to DOX.
Conclusions: This study demonstrated that simultaneous administration of CBD and DOX can increase antitumoral effect and reduce DOX cardiotoxicity. Nevertheless, CBD can induce cardiotoxicity as administrated alone.
Keywords: breast cancer, cannabidiol, cardiotoxicity, doxorubicin, lung metastasis
© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.
References
-
- M. E. Gonzalez, E. E. Martin, T. Anwar, et al., “Mesenchymal Stem Cell‐Induced DDR2 Mediates Stromal‐Breast Cancer Interactions and Metastasis Growth,” Cell Reports 18, no. 5 (2017): 1215–1228.
-
- X. Zhao, Q. Wang, S. Yang, et al., “Quercetin Inhibits Angiogenesis by Targeting Calcineurin in the Xenograft Model of Human Breast Cancer,” European Journal of Pharmacology 781 (2016): 60–68.
-
- Z. Tu and A. E. Karnoub, “Mesenchymal Stem/Stromal Cells in Breast Cancer Development and Management,” Seminars in Cancer Biology 86 (2022): 81–92.
-
- L. Jin, B. Han, E. Siegel, Y. Cui, A. Giuliano, and X. Cui, “Breast Cancer Lung Metastasis: Molecular Biology and Therapeutic Implications,” Cancer Biology & Therapy 19, no. 10 (2018): 858–868.
-
- L. Monteran, N. Ershaid, H. Doron, et al., “Chemotherapy‐Induced Complement Signaling Modulates Immunosuppression and Metastatic Relapse in Breast Cancer,” Nature Communications 13, no. 1 (2022): 5797.